HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > Market Data Forecast.

Print e mail rss del Y! myWeb Tweet
 

North America Cancer Monoclonal Antibodies Market is Expected to reach 17 billion by 2021

Research report by marketdataforecast.com with in-depth analysis North America Cancer Monoclonal Antibodies Market, which provides information on market size, share, forecasts and company profiles for major industry participants 2016-2021

 



(EMAILWIRE.COM, March 10, 2017 ) According to the report North America Cancer Monoclonal Antibodies Market, published by Market Data Forecast, the North America market is projected to reach USD 17 billion by 2020, at a CAGR of 10.5% from 2015 to 2020

For full report refer to http://www.marketdataforecast.com/market-reports/north-america-cancer-monoclonal-antibodies-market-187/

Cancer is a severe disease causing millions of death worldwide every year. Cancer starts from a single cell and genetically transforms a normal cell in to tumour cell and is gradually spread to other cells. With the dramatic increase in the number of people affected by cancer, many pharmaceutical players started to invest on monoclonal antibodies. While the drugs are used for the treatment of cancer, drugs like chemotherapy agents have adverse side effects as they affect the normal cells as well along with cancerous cells. This promoted the increased usage of Monoclonal Antibodies for the treatment of cancer.

Recent years have seen the emergence of monoclonal antibodies owing to its potentiality to offer less toxic and highly efficient alternatives to the patients. The antibodies have the ability to treat many diseases related to autoimmune, inflammatory and especially cancer. The antibodies comprises of identical cells which are clones of a single parent cells and directed towards specific targets cells. Thus monoclonal antibodies due to its specificity to target only cancer cell leaving behind the healthy one, can be a more efficient way of treating cancer than chemotherapies or drugs.

Free sample of the report is available at http://www.marketdataforecast.com/market-reports/north-america-cancer-monoclonal-antibodies-market-187/request-sample

The drastic increase in the people affected by cancer prompted many pharmaceutical firms to invest in monoclonal antibodies. Rise in investment in R&D of genomic studies, monoclonal antibodies ability to target only specific cells, technological innovations in target gene selection and genetic sequencing, having no side effects compared to its counter parts are the primary drivers for the market. With the increased occurrence of cancer, the market is expected to grow significantly in the next 5 years having a presence of highly strong products in the pipeline. There are also few restraints for its market entry like stringent guidelines, high cost, long durations required for R&D, clinical trials.

Enquire more about the report here http://www.marketdataforecast.com/market-reports/north-america-cancer-monoclonal-antibodies-market-187/inquire

The Cancer Monoclonal Antibodies Market is segmented as following:
Based on Application:
• Liver
• Breast
• Brain
• Blood
• Hodgkins and Non-Hodgkins lymphoma
• Colorectal
• Leukaemia
• Others
Based on Type:
• Murine Antibodies
• Chimeric and Humanised Antibodies
• Fully Humanized Antibodies
Based on Conjugate Cancer Therapies:
• Immunoliposome
• Radioimmunotherapy
• ADEPT
• Immunocytokines
• Others

The major companies operating in the North America Cancer Monoclonal Antibodies Market are Amgen, Bristol Myers Squibb, Roche, Immunogen, Novartis, Genmab, glaxosmithkline, Seattle Genetics, Eli Lilly, and Spectrum Pharmaceuticals.

Buy now http://www.marketdataforecast.com/market-reports/north-america-cancer-monoclonal-antibodies-market-187/

The Cancer Monoclonal Antibodies Market study offers the following deliverables:
• North America, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the North America market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Pharmaceuticals Segment:

North America Anticoccidial Drugs Market: http://www.marketdataforecast.com/market-reports/north-america-anticoccidial-drugs-market-22/

North America Anti-Aging Market: http://www.marketdataforecast.com/market-reports/north-america-anti-aging-market-1399/

North America Antifungal Drugs Market: http://www.marketdataforecast.com/market-reports/north-america-anti-fungal-drugs-market-245/

North America Antivenom Market: http://www.marketdataforecast.com/market-reports/north-america-antivenom-market-1581/

North America Antiviral Drugs Market: http://www.marketdataforecast.com/market-reports/north-america-antiviral-drugs-market-1588/

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results


 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2023